,SUMMARY,SCIENTIFIC JUSTIFICATION,PROCEDURE,OBJECTIVES,METHODOLOGY,ELIGIBILITY,DATA MANAGEMENT,STATISTICAL,total
patients,708.0,86.0,145.0,42.0,49.0,90.0,0.0,100.0,1220.0
study,366.0,27.0,334.0,17.0,22.0,108.0,89.0,39.0,1002.0
treatment,336.0,26.0,121.0,33.0,50.0,87.0,0.0,84.0,737.0
day,252.0,0.0,72.0,39.0,53.0,0.0,0.0,0.0,416.0
must,0.0,0.0,365.0,0.0,0.0,30.0,0.0,0.0,395.0
trial,209.0,0.0,87.0,0.0,0.0,36.0,0.0,54.0,386.0
investigator,0.0,0.0,383.0,0.0,0.0,0.0,0.0,0.0,383.0
months,233.0,0.0,0.0,20.0,53.0,67.0,0.0,0.0,373.0
clinical,174.0,12.0,70.0,26.0,36.0,0.0,35.0,0.0,353.0
disease,216.0,30.0,0.0,16.0,28.0,57.0,0.0,0.0,347.0
patient,112.0,0.0,127.0,0.0,0.0,67.0,0.0,0.0,306.0
inclusion,183.0,0.0,0.0,12.0,31.0,80.0,0.0,0.0,306.0
sponsor,0.0,0.0,233.0,0.0,0.0,0.0,48.0,0.0,281.0
cell,193.0,28.0,0.0,14.0,0.0,41.0,0.0,0.0,276.0
data,0.0,0.0,161.0,0.0,0.0,0.0,79.0,32.0,272.0
gvhd,182.0,21.0,0.0,31.0,26.0,0.0,0.0,0.0,260.0
participant,0.0,0.0,238.0,0.0,0.0,0.0,19.0,0.0,257.0
response,101.0,0.0,0.0,28.0,72.0,0.0,0.0,52.0,253.0
form,0.0,0.0,241.0,0.0,0.0,0.0,0.0,0.0,241.0
days,141.0,0.0,0.0,21.0,30.0,43.0,0.0,0.0,235.0
non,121.0,13.0,0.0,19.0,23.0,0.0,22.0,34.0,232.0
years,143.0,22.0,0.0,0.0,0.0,64.0,0.0,0.0,229.0
criteria,128.0,0.0,0.0,0.0,36.0,63.0,0.0,0.0,227.0
adverse,0.0,0.0,195.0,0.0,23.0,0.0,0.0,0.0,218.0
safety,0.0,0.0,149.0,14.0,23.0,0.0,0.0,29.0,215.0
sae,0.0,0.0,204.0,0.0,0.0,0.0,0.0,0.0,204.0
12,122.0,0.0,0.0,23.0,58.0,0.0,0.0,0.0,203.0
10,185.0,11.0,0.0,0.0,0.0,0.0,0.0,0.0,196.0
primary,102.0,0.0,0.0,13.0,25.0,0.0,0.0,53.0,193.0
severe,140.0,18.0,0.0,0.0,0.0,31.0,0.0,0.0,189.0
week,106.0,0.0,0.0,27.0,53.0,0.0,0.0,0.0,186.0
pregnancy,0.0,0.0,157.0,0.0,0.0,28.0,0.0,0.0,185.0
number,122.0,0.0,0.0,0.0,27.0,0.0,0.0,31.0,180.0
dose,130.0,0.0,0.0,0.0,0.0,46.0,0.0,0.0,176.0
transplantation,147.0,29.0,0.0,0.0,0.0,0.0,0.0,0.0,176.0
using,0.0,0.0,0.0,0.0,38.0,0.0,0.0,134.0,172.0
efficacy,98.0,15.0,0.0,21.0,0.0,0.0,0.0,38.0,172.0
report,0.0,0.0,170.0,0.0,0.0,0.0,0.0,0.0,170.0
follow,0.0,0.0,169.0,0.0,0.0,0.0,0.0,0.0,169.0
active,102.0,0.0,0.0,0.0,0.0,67.0,0.0,0.0,169.0
uveitis,132.0,23.0,0.0,12.0,0.0,0.0,0.0,0.0,167.0
cells,123.0,24.0,0.0,16.0,0.0,0.0,0.0,0.0,163.0
research,0.0,0.0,115.0,0.0,0.0,0.0,48.0,0.0,163.0
randomized,104.0,15.0,0.0,0.0,0.0,0.0,0.0,42.0,161.0
donor,100.0,22.0,0.0,0.0,0.0,38.0,0.0,0.0,160.0
notification,0.0,0.0,160.0,0.0,0.0,0.0,0.0,0.0,160.0
event,0.0,0.0,160.0,0.0,0.0,0.0,0.0,0.0,160.0
arm,103.0,0.0,0.0,0.0,0.0,0.0,0.0,57.0,160.0
msc,158.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,158.0
case,0.0,0.0,158.0,0.0,0.0,0.0,0.0,0.0,158.0
first,117.0,12.0,0.0,0.0,28.0,0.0,0.0,0.0,157.0
use,103.0,18.0,0.0,0.0,0.0,35.0,0.0,0.0,156.0
relapse,98.0,0.0,0.0,24.0,32.0,0.0,0.0,0.0,154.0
information,0.0,0.0,103.0,0.0,0.0,0.0,49.0,0.0,152.0
therapy,104.0,0.0,0.0,0.0,0.0,47.0,0.0,0.0,151.0
subject,0.0,0.0,96.0,0.0,0.0,33.0,18.0,0.0,147.0
transplant,133.0,12.0,0.0,0.0,0.0,0.0,0.0,0.0,145.0
et,118.0,26.0,0.0,0.0,0.0,0.0,0.0,0.0,144.0
department,0.0,0.0,139.0,0.0,0.0,0.0,0.0,0.0,139.0
anti,117.0,22.0,0.0,0.0,0.0,0.0,0.0,0.0,139.0
risk,121.0,18.0,0.0,0.0,0.0,0.0,0.0,0.0,139.0
al,109.0,25.0,0.0,0.0,0.0,0.0,0.0,0.0,134.0
following,0.0,0.0,65.0,0.0,28.0,41.0,0.0,0.0,134.0
consent,0.0,0.0,83.0,0.0,0.0,48.0,0.0,0.0,131.0
defined,0.0,0.0,0.0,0.0,94.0,32.0,0.0,0.0,126.0
mg,126.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,126.0
used,0.0,11.0,75.0,0.0,0.0,0.0,0.0,38.0,124.0
blood,109.0,0.0,0.0,12.0,0.0,0.0,0.0,0.0,121.0
analysis,0.0,0.0,0.0,0.0,24.0,0.0,0.0,95.0,119.0
documents,0.0,0.0,117.0,0.0,0.0,0.0,0.0,0.0,117.0
may,0.0,15.0,100.0,0.0,0.0,0.0,0.0,0.0,115.0
refractory,101.0,14.0,0.0,0.0,0.0,0.0,0.0,0.0,115.0
acute,115.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,115.0
kg,111.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,111.0
serious,0.0,0.0,108.0,0.0,0.0,0.0,0.0,0.0,108.0
performed,0.0,0.0,62.0,0.0,0.0,0.0,0.0,45.0,107.0
reports,0.0,0.0,103.0,0.0,0.0,0.0,0.0,0.0,103.0
subjects,0.0,0.0,0.0,0.0,0.0,34.0,21.0,47.0,102.0
rate,0.0,0.0,0.0,15.0,40.0,0.0,0.0,46.0,101.0
de,101.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,101.0
duration,99.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,99.0
one,99.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,99.0
results,0.0,12.0,64.0,0.0,0.0,0.0,22.0,0.0,98.0
complete,0.0,0.0,72.0,0.0,25.0,0.0,0.0,0.0,97.0
french,0.0,0.0,61.0,0.0,0.0,0.0,33.0,0.0,94.0
initial,0.0,0.0,93.0,0.0,0.0,0.0,0.0,0.0,93.0
prior,0.0,0.0,0.0,0.0,0.0,92.0,0.0,0.0,92.0
time,0.0,0.0,0.0,14.0,45.0,0.0,0.0,31.0,90.0
within,0.0,0.0,0.0,0.0,0.0,82.0,0.0,0.0,82.0
crf,0.0,0.0,81.0,0.0,0.0,0.0,0.0,0.0,81.0
vigilance,0.0,0.0,81.0,0.0,0.0,0.0,0.0,0.0,81.0
incidence,0.0,0.0,0.0,17.0,31.0,0.0,0.0,31.0,79.0
possible,0.0,0.0,79.0,0.0,0.0,0.0,0.0,0.0,79.0
email,0.0,0.0,78.0,0.0,0.0,0.0,0.0,0.0,78.0
m12,0.0,0.0,0.0,0.0,75.0,0.0,0.0,0.0,75.0
assessment,0.0,0.0,74.0,0.0,0.0,0.0,0.0,0.0,74.0
evaluate,0.0,0.0,0.0,73.0,0.0,0.0,0.0,0.0,73.0
according,0.0,0.0,0.0,0.0,43.0,30.0,0.0,0.0,73.0
additional,0.0,0.0,71.0,0.0,0.0,0.0,0.0,0.0,71.0
reason,0.0,0.0,70.0,0.0,0.0,0.0,0.0,0.0,70.0
survival,0.0,15.0,0.0,28.0,25.0,0.0,0.0,0.0,68.0
medical,0.0,0.0,66.0,0.0,0.0,0.0,0.0,0.0,66.0
send,0.0,0.0,65.0,0.0,0.0,0.0,0.0,0.0,65.0
endpoint,0.0,0.0,0.0,0.0,23.0,0.0,0.0,42.0,65.0
m6,0.0,0.0,0.0,0.0,65.0,0.0,0.0,0.0,65.0
aphp,0.0,0.0,63.0,0.0,0.0,0.0,0.0,0.0,63.0
test,0.0,0.0,0.0,0.0,0.0,0.0,0.0,63.0,63.0
quality,0.0,0.0,0.0,15.0,0.0,0.0,47.0,0.0,62.0
participants,0.0,0.0,0.0,0.0,0.0,0.0,62.0,0.0,62.0
hospital,0.0,0.0,61.0,0.0,0.0,0.0,0.0,0.0,61.0
premature,0.0,0.0,61.0,0.0,0.0,0.0,0.0,0.0,61.0
infection,0.0,0.0,0.0,0.0,0.0,59.0,0.0,0.0,59.0
m3,0.0,0.0,0.0,0.0,58.0,0.0,0.0,0.0,58.0
95,0.0,0.0,0.0,0.0,0.0,0.0,0.0,58.0,58.0
code,0.0,0.0,0.0,0.0,0.0,0.0,55.0,0.0,55.0
analyses,0.0,0.0,0.0,0.0,0.0,0.0,0.0,55.0,55.0
events,0.0,0.0,0.0,0.0,27.0,0.0,0.0,27.0,54.0
effect,0.0,0.0,0.0,28.0,0.0,0.0,0.0,26.0,54.0
least,0.0,0.0,0.0,0.0,0.0,52.0,0.0,0.0,52.0
24,0.0,0.0,0.0,12.0,39.0,0.0,0.0,0.0,51.0
based,0.0,0.0,0.0,0.0,0.0,0.0,0.0,50.0,50.0
probability,0.0,0.0,0.0,0.0,0.0,0.0,0.0,50.0,50.0
endpoints,0.0,0.0,0.0,0.0,0.0,0.0,0.0,49.0,49.0
grade,0.0,0.0,0.0,12.0,37.0,0.0,0.0,0.0,49.0
arms,0.0,0.0,0.0,0.0,0.0,0.0,0.0,49.0,49.0
investigators,0.0,0.0,0.0,0.0,0.0,0.0,48.0,0.0,48.0
history,0.0,0.0,0.0,0.0,0.0,47.0,0.0,0.0,47.0
control,0.0,0.0,0.0,0.0,0.0,0.0,46.0,0.0,46.0
estimated,0.0,0.0,0.0,0.0,0.0,0.0,0.0,46.0,46.0
necessary,0.0,0.0,0.0,0.0,0.0,0.0,45.0,0.0,45.0
failure,0.0,0.0,0.0,13.0,0.0,32.0,0.0,0.0,45.0
group,0.0,0.0,0.0,13.0,0.0,0.0,0.0,31.0,44.0
ensure,0.0,0.0,0.0,0.0,0.0,0.0,44.0,0.0,44.0
baseline,0.0,0.0,0.0,12.0,31.0,0.0,0.0,0.0,43.0
characteristics,0.0,0.0,0.0,0.0,0.0,0.0,0.0,42.0,42.0
persons,0.0,0.0,0.0,0.0,0.0,0.0,41.0,0.0,41.0
contraception,0.0,0.0,0.0,0.0,0.0,41.0,0.0,0.0,41.0
m24,0.0,0.0,0.0,0.0,41.0,0.0,0.0,0.0,41.0
overall,0.0,0.0,0.0,17.0,23.0,0.0,0.0,0.0,40.0
two,0.0,0.0,0.0,0.0,0.0,0.0,0.0,40.0,40.0
compared,0.0,0.0,0.0,0.0,0.0,0.0,0.0,40.0,40.0
secondary,0.0,0.0,0.0,13.0,0.0,0.0,0.0,26.0,39.0
interim,0.0,0.0,0.0,0.0,0.0,0.0,0.0,38.0,38.0
positive,0.0,0.0,0.0,0.0,0.0,38.0,0.0,0.0,38.0
bd,0.0,37.0,0.0,0.0,0.0,0.0,0.0,0.0,37.0
weeks,0.0,0.0,0.0,0.0,0.0,37.0,0.0,0.0,37.0
methods,0.0,0.0,0.0,0.0,0.0,37.0,0.0,0.0,37.0
226,0.0,0.0,0.0,0.0,0.0,0.0,36.0,0.0,36.0
bayesian,0.0,0.0,0.0,0.0,0.0,0.0,0.0,36.0,36.0
informed,0.0,0.0,0.0,0.0,0.0,35.0,0.0,0.0,35.0
assessed,0.0,0.0,0.0,0.0,34.0,0.0,0.0,0.0,34.0
compare,0.0,0.0,0.0,34.0,0.0,0.0,0.0,0.0,34.0
carcinoma,0.0,0.0,0.0,0.0,0.0,33.0,0.0,0.0,33.0
median,0.0,0.0,0.0,0.0,0.0,0.0,0.0,33.0,33.0
described,0.0,0.0,0.0,0.0,0.0,0.0,0.0,32.0,32.0
age,0.0,0.0,0.0,0.0,0.0,32.0,0.0,0.0,32.0
potential,0.0,0.0,0.0,0.0,0.0,32.0,0.0,0.0,32.0
m1,0.0,0.0,0.0,0.0,32.0,0.0,0.0,0.0,32.0
women,0.0,0.0,0.0,0.0,0.0,32.0,0.0,0.0,32.0
design,0.0,0.0,0.0,0.0,0.0,0.0,0.0,30.0,30.0
18,0.0,0.0,0.0,0.0,0.0,30.0,0.0,0.0,30.0
model,0.0,0.0,0.0,0.0,0.0,0.0,0.0,30.0,30.0
posterior,0.0,0.0,0.0,0.0,0.0,0.0,0.0,29.0,29.0
drug,0.0,0.0,0.0,0.0,0.0,0.0,0.0,29.0,29.0
treat,0.0,0.0,0.0,0.0,0.0,0.0,0.0,29.0,29.0
included,0.0,0.0,0.0,0.0,0.0,28.0,0.0,0.0,28.0
systemic,0.0,0.0,0.0,0.0,0.0,28.0,0.0,0.0,28.0
intent,0.0,0.0,0.0,0.0,0.0,0.0,0.0,27.0,27.0
last,0.0,0.0,0.0,0.0,0.0,27.0,0.0,0.0,27.0
visit,0.0,0.0,0.0,0.0,0.0,27.0,0.0,0.0,27.0
set,0.0,0.0,0.0,0.0,0.0,0.0,0.0,27.0,27.0
range,0.0,0.0,0.0,0.0,0.0,0.0,0.0,27.0,27.0
heart,0.0,0.0,0.0,0.0,0.0,27.0,0.0,0.0,27.0
50,0.0,0.0,0.0,0.0,0.0,27.0,0.0,0.0,27.0
16,0.0,0.0,0.0,0.0,27.0,0.0,0.0,0.0,27.0
statistical,0.0,0.0,0.0,0.0,0.0,0.0,0.0,26.0,26.0
hepatitis,0.0,0.0,0.0,0.0,0.0,26.0,0.0,0.0,26.0
remission,0.0,0.0,0.0,0.0,26.0,0.0,0.0,0.0,26.0
m0,0.0,0.0,0.0,0.0,26.0,0.0,0.0,0.0,26.0
including,0.0,0.0,0.0,0.0,0.0,26.0,0.0,0.0,26.0
tumor,0.0,13.0,0.0,13.0,0.0,0.0,0.0,0.0,26.0
haplo,0.0,25.0,0.0,0.0,0.0,0.0,0.0,0.0,25.0
collected,0.0,0.0,0.0,0.0,0.0,0.0,25.0,0.0,25.0
score,0.0,0.0,0.0,0.0,24.0,0.0,0.0,0.0,24.0
personal,0.0,0.0,0.0,0.0,0.0,0.0,24.0,0.0,24.0
obtained,0.0,0.0,0.0,0.0,0.0,0.0,24.0,0.0,24.0
without,0.0,0.0,0.0,0.0,24.0,0.0,0.0,0.0,24.0
well,0.0,0.0,0.0,0.0,0.0,0.0,24.0,0.0,24.0
free,0.0,11.0,0.0,13.0,0.0,0.0,0.0,0.0,24.0
responsible,0.0,0.0,0.0,0.0,0.0,0.0,23.0,0.0,23.0
names,0.0,0.0,0.0,0.0,0.0,0.0,23.0,0.0,23.0
month,0.0,0.0,0.0,0.0,23.0,0.0,0.0,0.0,23.0
evaluated,0.0,0.0,0.0,0.0,23.0,0.0,0.0,0.0,23.0
take,0.0,0.0,0.0,0.0,0.0,0.0,22.0,0.0,22.0
strictly,0.0,0.0,0.0,0.0,0.0,0.0,22.0,0.0,22.0
via,0.0,0.0,0.0,0.0,0.0,0.0,22.0,0.0,22.0
precautions,0.0,0.0,0.0,0.0,0.0,0.0,22.0,0.0,22.0
professional,0.0,0.0,0.0,0.0,0.0,0.0,22.0,0.0,22.0
addresses,0.0,0.0,0.0,0.0,0.0,0.0,22.0,0.0,22.0
circumstances,0.0,0.0,0.0,0.0,0.0,0.0,22.0,0.0,22.0
confidentiality,0.0,0.0,0.0,0.0,0.0,0.0,22.0,0.0,22.0
identifying,0.0,0.0,0.0,0.0,0.0,0.0,22.0,0.0,22.0
identity,0.0,0.0,0.0,0.0,0.0,0.0,22.0,0.0,22.0
secrecy,0.0,0.0,0.0,0.0,0.0,0.0,22.0,0.0,22.0
shown,0.0,0.0,0.0,0.0,0.0,0.0,21.0,0.0,21.0
assess,0.0,0.0,0.0,21.0,0.0,0.0,0.0,0.0,21.0
sent,0.0,0.0,0.0,0.0,0.0,0.0,21.0,0.0,21.0
specialised,0.0,0.0,0.0,0.0,0.0,0.0,21.0,0.0,21.0
particular,0.0,0.0,0.0,0.0,0.0,0.0,21.0,0.0,21.0
unrelated,0.0,20.0,0.0,0.0,0.0,0.0,0.0,0.0,20.0
bound,0.0,0.0,0.0,0.0,0.0,0.0,19.0,0.0,19.0
articles,0.0,0.0,0.0,0.0,0.0,0.0,19.0,0.0,19.0
relating,0.0,0.0,0.0,0.0,0.0,0.0,19.0,0.0,19.0
hsct,0.0,19.0,0.0,0.0,0.0,0.0,0.0,0.0,19.0
article,0.0,0.0,0.0,0.0,0.0,0.0,19.0,0.0,19.0
web,0.0,0.0,0.0,0.0,0.0,0.0,19.0,0.0,19.0
immune,0.0,0.0,0.0,19.0,0.0,0.0,0.0,0.0,19.0
collaborators,0.0,0.0,0.0,0.0,0.0,0.0,18.0,0.0,18.0
1121,0.0,0.0,0.0,0.0,0.0,0.0,18.0,0.0,18.0
13,0.0,0.0,0.0,0.0,0.0,0.0,18.0,0.0,18.0
life,0.0,0.0,0.0,16.0,0.0,0.0,0.0,0.0,16.0
reported,0.0,16.0,0.0,0.0,0.0,0.0,0.0,0.0,16.0
prophylaxis,0.0,0.0,0.0,16.0,0.0,0.0,0.0,0.0,16.0
vasculitis,0.0,16.0,0.0,0.0,0.0,0.0,0.0,0.0,16.0
estimate,0.0,0.0,0.0,15.0,0.0,0.0,0.0,0.0,15.0
pd,0.0,15.0,0.0,0.0,0.0,0.0,0.0,0.0,15.0
objective,0.0,0.0,0.0,14.0,0.0,0.0,0.0,0.0,14.0
change,0.0,0.0,0.0,14.0,0.0,0.0,0.0,0.0,14.0
terms,0.0,0.0,0.0,14.0,0.0,0.0,0.0,0.0,14.0
mammography,0.0,0.0,0.0,14.0,0.0,0.0,0.0,0.0,14.0
related,0.0,13.0,0.0,0.0,0.0,0.0,0.0,0.0,13.0
matched,0.0,13.0,0.0,0.0,0.0,0.0,0.0,0.0,13.0
associated,0.0,13.0,0.0,0.0,0.0,0.0,0.0,0.0,13.0
100,0.0,0.0,0.0,12.0,0.0,0.0,0.0,0.0,12.0
21,0.0,0.0,0.0,12.0,0.0,0.0,0.0,0.0,12.0
sct,0.0,12.0,0.0,0.0,0.0,0.0,0.0,0.0,12.0
hla,0.0,11.0,0.0,0.0,0.0,0.0,0.0,0.0,11.0
identical,0.0,11.0,0.0,0.0,0.0,0.0,0.0,0.0,11.0
cryoglobulinemia,0.0,11.0,0.0,0.0,0.0,0.0,0.0,0.0,11.0
also,0.0,11.0,0.0,0.0,0.0,0.0,0.0,0.0,11.0
major,0.0,11.0,0.0,0.0,0.0,0.0,0.0,0.0,11.0
stem,0.0,11.0,0.0,0.0,0.0,0.0,0.0,0.0,11.0
studies,0.0,11.0,0.0,0.0,0.0,0.0,0.0,0.0,11.0
thus,0.0,11.0,0.0,0.0,0.0,0.0,0.0,0.0,11.0
